Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

  • 1 of 1

The team said the results indicate that the prophylactic used of lisinopril or carvedilol should be considered in those patients who could benefit from anthracycline treatment prior to trastuzumab

Study found that for HER2-positive breast cancer patients who received an anthracycline alongside trastuzumab, cardiac prophylaxis, in the form of an ACE inhibitor (pictured) or beta-blocker, decreased the rate of cardiotoxicity by around 50%